Clozapine Rechallenge Following Neuroleptic Malignant Syndrome
نویسندگان
چکیده
منابع مشابه
Clozapine rechallenge following clozapine-induced pericarditis.
To the Editor: There are many reports describing the development of myocarditis and cardiomyopathy following treatment with clozapine. Fewer reports exist about the development of pericarditis, and reports of successful rechallenges with clozapine following the development of pericarditis are particularly rare. We report the case of a patient successfully resumed on clozapine treatment followin...
متن کاملOlanzapine-Induced Neuroleptic Malignant Syndrome
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening idiosyncratic side effect resulting from neuroleptic drugs. NMS mainly occurs in patients treated with high-potency typical antipsychotics, but rarely caused by atypical antipsychotics. Although NMS is less common with atypical antipsychotic, but it seems that its incidence is rising due to increased administration of such drug...
متن کاملCase report on clozapine-associated neuroleptic malignant syndrome
ABSTRACT This article summarizes the clinical manifestations of one case of clozapine-associated neuroleptic malignant syndrome and discusses its diagnosis, predisposing factors and treatment based on a literature review. Early identification and treatment is critical to lower the mortality of clozapine-associated neuroleptic malignant syndrome.
متن کاملAtypical Neuroleptic Malignant Syndrome Associated with Use of Clozapine
The Neuroleptic Malignant Syndrome (NMS) is a medical emergency of infrequent presentation in the emergency department, which is associated with the use of psychiatric drugs, such as typical and atypical antipsychotics. Our case addresses a 55-year-old patient diagnosed with undifferentiated schizophrenia for 10 years, who had been receiving clozapine and clonazepam as part of their treatment. ...
متن کاملSuspected neuroleptic malignant syndrome during quetiapine-clozapine cross-titration.
Neuroleptic malignant syndrome (NMS) is a physiologic phenomenon that has been associated with the use of both first- and second-generation antipsychotics resultant to their ability to block dopamine blockade in the basal ganglia and hypothalamic regions of the brain. The typical reaction involves the presentation of muscle rigidity, changes in mental status, temperature elevation, labile blood...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Clinical Psychopharmacology
سال: 2019
ISSN: 1533-712X,0271-0749
DOI: 10.1097/jcp.0000000000001048